Brief communication: temporal trends of chronic diseases medications prescriptions among HIV-infected patients in Belgium: a 4-year population-based study using pharmacy claims data

IF 2.1 4区医学 Q3 INFECTIOUS DISEASES

AIDS Research and Therapy Pub Date : 2024-07-27 DOI:10.1186/s12981-024-00634-3

Dieudonné Ilboudo, Calypse Ngwasiri, Isabelle Savoye, Agnès Sommet, Dominique Van Beckhoven, Jean Cyr Yombi, Fati Kirakoya-Samadoulougou

引用次数: 0

Abstract

The Objective of this study was to examine change over time of prevalence of chronic diseases medications (CDM) prescriptions among People living with HIV (PLWH) in Belgium, using Pharmanet database from 2018 to 2021. We identified 13,570, 14,175, 14,588 and 14,813 PLWH in 2018, 2019, 2020 and 2021, respectively. Prescriptions of cardiovascular diseases (CVD) medications (31.7–37.2%) and antidiabetics (7.4–9.0%), increased significantly (p for trend < 0.001 for all), while the prescription of neurological and mental disorders medications (18.0–19.3%) remained stable (p for trend = 0.11) and the prescription of chronic respiratory diseases (CRD) medications decreased from 12.2 to 10.6% (p for trend < 0.001), between 2018 and 2021. It is imperative to ensure that these medications are used appropriately.

查看原文本刊更多论文

简讯：比利时艾滋病毒感染者慢性病处方用药的时间趋势：利用药房报销数据进行的为期 4 年的人群研究

本研究的目的是利用Pharmanet数据库，研究2018年至2021年比利时艾滋病病毒感染者（PLWH）中慢性病药物（CDM）处方流行率随时间的变化。我们在 2018 年、2019 年、2020 年和 2021 年分别确定了 13570、14175、14588 和 14813 名艾滋病病毒感染者。在2018年至2021年期间，心血管疾病（CVD）药物（31.7%-37.2%）和抗糖尿病药物（7.4%-9.0%）的处方量显著增加（趋势均<0.001），而神经和精神障碍药物的处方量（18.0%-19.3%）保持稳定（趋势均=0.11），慢性呼吸系统疾病（CRD）药物的处方量从12.2%降至10.6%（趋势均<0.001）。当务之急是确保这些药物的合理使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

AIDS Research and Therapy INFECTIOUS DISEASES-

CiteScore

3.80

自引率

4.50%

发文量

审稿时长

16 weeks

期刊介绍： AIDS Research and Therapy publishes articles on basic science, translational, clinical, social, epidemiological, behavioral and educational sciences articles focused on the treatment and prevention of HIV/AIDS, and the search for the cure. The Journal publishes articles on novel and developing treatment strategies for AIDS as well as on the outcomes of established treatment strategies. Original research articles on animal models that form an essential part of the AIDS treatment research are also considered